Core A: Animals Models-Stoltz
核心A:动物模型-Stoltz
基本信息
- 批准号:10470206
- 负责人:
- 金额:$ 71.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-05 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:ATP12A geneAddressAffectAirway DiseaseAnimal ModelAnimalsBiliary cirrhosisBiologicalBloodBronchoalveolar Lavage FluidCaringChronicConsultationsCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDiseaseDisease ProgressionEnsureExocrine pancreasFamily suidaeGallbladderGenesGenetic DiseasesGenetic EngineeringGoalsHarvestHumanHuman ResourcesInfectionInflammationIntestinal ObstructionIntestinesKnowledgeLifeLiverLungMale Genital OrgansModelingMonitorMorbidity - disease rateNeonatalOrganPancreasPathogenesisPatientsPreventionProductionProgram Research Project GrantsPulmonary Cystic FibrosisResearch PersonnelRespiratory FailureRespiratory Tract InfectionsSamplingSinusStructural defectSweat GlandsTimeVas deferens structureairway inflammationanimal carecystic fibrosis airwaydisease-causing mutationexperiencehealth assessmentimprovedmortalityporcine modelprogramsrecurrent infectionreproductive tractsample collectionsuccess
项目摘要
CORE A – ANIMAL MODELS
PROJECT SUMMARY
Cystic fibrosis (CF) is a common autosomal recessive disease caused by mutations in the gene encoding the
cystic fibrosis transmembrane conductance regulator (CFTR). CF affects multiple organs, including lungs,
pancreas, intestine, liver, sweat glands, gallbladder and the male genital tract. Airway infection and
inflammation currently cause most of the morbidity and mortality. Although several therapies have improved
the lives of patients, current treatments are inadequate and CF remains a lethal disease. Our knowledge
about the pathogenesis of the disease, its progression, and the state of the neonatal lung is inadequate.
These gaps in our knowledge have hindered attempts to develop better treatments and preventions for CF
lung disease. A major impediment to addressing these issues had been limitations of animal models. We
generated CF pigs that replicate many of the key features of human CF disease including intestinal
obstruction, exocrine pancreatic destruction, micro-gallbladder, vas deferens abnormalities, focal biliary
cirrhosis, congenital airway structural abnormalities, and airway and sinus infection with time. The goals of the
Animal Models Core will be to (1): Provide Program investigators with non-CF and CF pigs so that they can
successfully complete their project aims; (2) Build new genetically engineered CF pig models; (3) Assist
projects in the harvesting of biologic samples from live animals (e.g., bronchoalveolar lavage fluid and blood),
the care and analysis of study animals, record keeping, and coordinate animal usage among projects. The
Animal Models Core will function seamlessly through already established interactions with the Project Leaders
and Core Directors. The success of the Animal Models Core is ensured because of the commitment,
experience, and expertise that the personnel bring to the Core.
核心A-动物模型
项目摘要
囊性纤维化(CF)是一种常见的常染色体隐性遗传病,由编码
囊性纤维化跨膜传导调节因子(CFTR)。CF影响多个器官,包括肺,
胰腺、肠、肝、汗腺、胆囊和男性生殖道。呼吸道感染和
炎症目前引起大部分的发病率和死亡率。虽然有几种疗法已经有所改善
然而,由于CF严重威胁患者的生命,目前的治疗是不充分的,并且CF仍然是致命的疾病。我们的知识
关于疾病的发病机制,其进展,以及新生儿肺的状态是不够的。
这些知识上的差距阻碍了我们为CF开发更好的治疗和预防方法的尝试
肺病。解决这些问题的主要障碍是动物模型的局限性。我们
产生的CF猪复制了人类CF疾病的许多关键特征,
梗阻,胰腺外分泌破坏,微胆囊,输精管异常,局灶性胆道
肝硬化、先天性气道结构异常和气道和鼻窦感染。的目标
动物模型核心将是(1):为项目研究者提供非CF和CF猪,以便他们能够
成功完成项目目标;(2)建立新的基因工程CF猪模型;(3)协助
从活体动物中采集生物样品的项目(例如,支气管肺泡灌洗液和血液),
研究动物的护理和分析,记录保存,并协调项目之间的动物使用。的
动物模型核心将通过与项目负责人已经建立的互动无缝运作
和核心董事。动物模型核心的成功是因为承诺,
经验和专业知识的人员带来的核心。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID A STOLTZ其他文献
FATAL LUNG INJURY SECONDARY TO TRIMETHOPRIM-SULFAMETHOXAZOLE
- DOI:
10.1016/j.chest.2023.07.1615 - 发表时间:
2023-10-01 - 期刊:
- 影响因子:
- 作者:
HALEY PYSICK;DAVID A STOLTZ - 通讯作者:
DAVID A STOLTZ
DAVID A STOLTZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID A STOLTZ', 18)}}的其他基金
Climate Change and Lung Health Training Program
气候变化与肺部健康培训计划
- 批准号:
10556149 - 财政年份:2023
- 资助金额:
$ 71.22万 - 项目类别:
Testing the Contributions of Airway Submucosal Glands and Surface Epithelia to Lung Health
测试气道粘膜下腺和表面上皮对肺部健康的贡献
- 批准号:
10597111 - 财政年份:2022
- 资助金额:
$ 71.22万 - 项目类别:
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis
气道碱化和重新利用氨丁三醇作为囊性纤维化的治疗方法
- 批准号:
10155587 - 财政年份:2017
- 资助金额:
$ 71.22万 - 项目类别:
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis
气道碱化和重新利用氨丁三醇作为囊性纤维化的治疗方法
- 批准号:
9289053 - 财政年份:2017
- 资助金额:
$ 71.22万 - 项目类别:
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis
气道碱化和重新利用氨丁三醇作为囊性纤维化的治疗方法
- 批准号:
9918957 - 财政年份:2017
- 资助金额:
$ 71.22万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 71.22万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 71.22万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 71.22万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 71.22万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 71.22万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 71.22万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 71.22万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 71.22万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 71.22万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 71.22万 - 项目类别:
Research Grant














{{item.name}}会员




